Women with low quality of life by cervantes-short form scale choose menopausal hormone therapy

Health-related quality of life and resilience in peri- and postmenopausal women during Covid-19 confinement

“…The scale is scored from 0 to 100, where 0 indicates the best and 100 the worst possible menopause related HRQoL [13,14]. A recent study on menopausal women has demonstrated the applicability of Cervantes-SF in the clinical practice [15]. The RS-14 (Spanish version) was used to assess resilience and to measure levels of psychological coping during Covid-19 confinement.…”

Predictive and criterion validity of the Cervantes-SF menopause quality of life questionnaire

“…To test predictive validity, we used the variation of the scale score by a magnitude equal to or greater than 1 SEM, which is 6.7 points 9 . The SEM is considered a good indicator of the MID of any instrument and is interpreted as the difference that is perceived by the patient when a change in their health has occurred that is detectable by the subject themselves and, therefore, relevant [26][27][28][29][30] . That is, a variation (both increase and decrease) in the Cervantes-SF scale score of 6.7 or more points would be due to a change in the woman's HRQoL in the peri/postmenopausal period that would be perceived by the woman herself as indicating that she has experienced a change in her health status.…”

“…In our work, women with moderate-to-severe vasomotor syndrome were shown to have a two to three times greater likelihood of undergoing pharmacological treatment (mainly MHT) than women for whom the severity of the syndrome is absent or mild, which supports the ability of the scale to identify women who require MHT when they present menopause symptoms associated with a poor quality of life, as previously shown in routine clinical practice. 30 While the other dimensions or subdomains of the scale were unable to predict moderateto-severe vasomotor syndrome, the predictive capacity of vasomotor and menopause and health subdomains for…”

“…The health outcomes used as a criterion (or dependent) variable to test the predictive validity of the Cervantes-SF were degree of impairment for performing work and daily activities (both expressed as a percentage) using the WPAI-GH scale, economic loss per person-year due to decreased work productivity (euros, year 2018), current self-reported health status using the EQ-VAS, years of healthy life expectancy without disability, daily hours of undisturbed (effective) sleep, and the variation in the number of annual medical visits due to menopausal symptoms. From the estimated models, we calculated, for each health outcome, the minimally important difference (MID), which is equivalent to the smallest change (both increase and decrease) in the total Cervantes-SF scale score perceived by the menopausal woman when a change in health-related quality of life has occurred due to menopausal symptoms [26][27][28][29] . In the total score of the Cervantes-SF scale, the magnitude of the MID is equivalent to 1 time the standard error of measurement (SEM) which is of a magnitude equal to 6.7 points in the total score of the scale, as previously mentioned.…”

Pharmacological interactions and menopausal hormone therapy: a review

“…Menopausal hormone therapy (HT) could be used to improve health-related quality of life in perimenopausal and postmenopausal women 1-3 according to the statements of international scientific societies 4-6 . Many midlife women are taking or will take medications for other conditions when HT is recommended; however, data about possible interactions are scarce.…”